Based on the characteristics of EFEMP2 in our research on ovarian cancer, we believed that EFEMP2 might be used as a targeted drug to effectively inhibit the invasion and metastasis of ovarian cancer in the future. This evidence concerns the gene EFEMP2 and ovarian cancer.